Biofeedback efficacy for outlet dysfunction constipation: Clinical outcomes and predictors of response by a limited approach

Christian Lambiase,Massimo Bellini,William E. Whitehead,Stefan Lucian Popa,Riccardo Morganti,Giuseppe Chiarioni
DOI: https://doi.org/10.1111/nmo.14948
2024-10-27
Neurogastroenterology & Motility
Abstract:Biofeedback (BF) is the therapy of choice for functional defecation disorders of any etiology. BF was reported as an effective short‐term cure for constipation in up to 63% of patients. A straining questionnaire and a digital rectal examination augmented with abdominal palpation on straining were associated to BF response. Background Functional defecation disorders (FDD) are a common etiology of refractory chronic constipation (CC). FDD diagnosis (dyssynergic defecation [DD] and inadequate defecatory propulsion [IDP]), requires diagnostic tests including anorectal manometry (ARM) and balloon expulsion test (BET). Biofeedback (BF) is the treatment of choice for DD. The aims of our study were to evaluate: the outcome of BF in a group of constipated patients with defecatory disorders of any etiology; the efficacy of two simple diagnostic tools in predicting BF outcome in the short‐term. Methods One hundred and thirty‐one refractory CC patients failing the BET underwent BF therapy. Before BF, all patients underwent the following: ARM. Straining questionnaire. The answers were: "belly muscles"; "anal muscles"; "both"; "Don't know/No answer." Digital rectal examination augmented by abdominal palpation on straining (augmented‐DRE). The BF therapist was blinded to ARM, straining questionnaire, and augmented‐DRE results. Key Results Eighty‐one patients responded to BF. Gender, age, and IBS‐C showed no significant impact on BF response. Both DD and IDP responded equally to BF, while the rate of response in patients with isolated structural pelvic floor abnormalities was lower (p
gastroenterology & hepatology,neurosciences,clinical neurology
What problem does this paper attempt to address?